[ad_1]
In the document to report the resumption of tests, the university indicates that about 18,000 people received this vaccine under study, as part of clinical trials, and that in tests as extensive as these, it is expected that some of the participants feel bad . .
“Each case must be carefully evaluated” to ensure the safety of the vaccine, adds the statement from the University of Oxford, which did not specify the date for the resumption of the trials.
Clinical trials in the UK will start again once the independent review process is complete.
“We cannot reveal medical information about the disease (of the volunteer) for reasons of confidentiality of the participant,” explains the university in its statement.
“We are committed to the safety of our participants at the highest level of conduct in our studies and we closely monitor the safety” of the vaccine, the document added.
The potential vaccine, which showed promising results in early trials, was undergoing clinical trials in the United Kingdom, the United States of America, Brazil and South Africa.
In August, the governments of Argentina and Mexico, as well as the Mexican Slim Foundation, reached an agreement with AstraZeneca and the University of Oxford to manufacture the vaccine for their countries and then distribute it to the rest of Latin America, with the exception of Brazil.
The president of Argentina, Alberto Fernández, reported in August that the goal was to prepare between 150 and 250 million doses that would be available at affordable prices, with an individual cost between three and four dollars.
The covid-19 pandemic has already claimed at least 916,372 deaths and more than 28.5 million cases of infection in 196 countries and territories, according to an assessment by the French agency AFP.
In Portugal, 1,855 people died from 62,813 confirmed cases of infection, according to the most recent bulletin from the Directorate General of Health.
The disease is transmitted by a new coronavirus detected in late December in Wuhan, a city in central China.
After Europe succeeded China as the center of the pandemic in February, the American continent is now the one with the most confirmed cases and the most deaths.
